Modulation of Fexofenadine Pharmacokinetics by Osimertinib in Patients With Advanced EGFR-Mutated Non-Small Cell Lung Cancer
published in: The Journal of Clinical Pharmacology
date of publication: 2019-03-15
main subject: non-small-cell lung carcinoma
Cites articles
There is nothing here
Article - wd:Q92387102